Platelet glycoprotein receptor IIIa polymorphism PlA1/PlA2 and coronary risk: A meta-analysis

Thrombosis and Haemostasis

Volumn 85, Issue 4, 2001, Pages 626-633

  Di Castelnuovo, A ^a   De Gaetano, G ^a   Donati, M B ^a   Iacoviello, L ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

Coronary disease; Genes; Meta analysis; PlA1 PlA2 polymorphism; Platelet glycoprotein

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIIA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORONARY STENT; DISEASE ASSOCIATION; DISEASE CARRIER; GENETIC CODE; GENETIC HETEROGENEITY; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; META ANALYSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RESTENOSIS; THROMBOCYTE FUNCTION; VASCULAR DISEASE;

EID: 0035071454     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615644     Document Type: Article

References (61)

1. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
2. Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance
3. The molecular immunology of human platelet proteins
4. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
5. Platelet glycoprotein IIIa P1A polymorphism and myocardial infarction
6. Platelet glycoprotein IIIa P1A polymorphism and myocardial infarction
7. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction
8. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
9. Association of the platelet P1 (A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease
10. The Leu33/Pro polymorphism (P1A1/P1A2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde
11. Glycoprotein IIIa polymorphism and risk of myocardial infarction
12. PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty
13. Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction
14. Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus
15. Association of the platelet glycoprotein IIIa P1A1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
16. Coronary thrombosis and the platelet glycoprotein IIIa gene PLA2 polymorphism
17. Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen 1b (HPA-1b/P1A2) is an inherited risk factor for premature myocardial infarction in coronary artery disease
18. Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis
19. Lipoprotein (a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction
20. Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty
21. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke
22. HPA-1 genotype in arterial thrombosis - Role of HPA-1b polymorphism in platelet function
23. The platelet PIA2 and ACE D allele polymorphisms are synergistic for the risk of recurrent events in patients post myocardial infarction and pravastatin reduces this risk
24. Prospective study of platelet PIA1/A2 polymorphism, platelet activation, and incidence of coronary heart disease
25. PECAM-1/CD31 and GPIIb/IIIa polymorphism and their roles in acute coronary thrombosis
26. Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators
27. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study
28. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population
29. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease
30. Prothrombotic genetic risk factors in young survivors of myocardial infarction
31. Analysis of platelet glycoproteins polymorphisms in patients with ischemic heart disease - A preliminary study in Polish population
32. Platelet polymorphisms of GPIa/IIa (Collagen) and GPIIb/IIIa (Fibrinogen) receptors and the risk of myocardial infarction
33. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans
34. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction
35. Platelet glycoprotein IIIa P1A polymorphism in young men with myocardial infarction
36. Lack of association between platelet glycoprotein IIb/IIIa receptor P1A polymorphism and coronary artery disease or carotid intima-media thickness
37. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans
38. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
39. Patients homozygous for the PIA2 allele coding for platelet glycoprotein IIIa are at increased risk for stent vessel thrombosis
40. P1A polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement
41. Quantitative methods in the review of epidemiologic literature
42. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group
43. Bias in meta-analysis detected by a simple, graphical test
44. ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites
45. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
46. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
47. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months . The EPIC Investigators
48. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group
49. P1A2 polymorphism and efficacy of aspirin
50. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation
51. Increased platelet aggregability associated with platelet GPIIIa P1A2 polymorphism: The Framingham Offspring Study
52. Platelet GP IIIa P1(A) polymorphisms display different sensitivities to agonists
53. Platelets from PLA2 (-) individuals bind more exogenous fibrinogen than platelet from PLA2 (+) individual
54. Interdonor variability of platelet response to thrombin receptor activation: Influence of P1A2 polymorphism
55. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, P1A2, Zwb) positive platelets in patients with cardiovascular disease
56. The P1(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions
57. Integrin polymorphisms as risk factors for thrombosis
58. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
59. Traditional reviews, meta-analyses and pooled analyses in epidemiology
60. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?